Furthermore, combining PTP@M and light (630 nm, 0.2 W/cm2, 5 min) treatment with the checkpoint inhibitor PD-1 (4 mg/kg) boosted tumor-infiltrating CD8+ T cell proliferation, resulting in greater tumor suppression and anti-metastasis effects. The gene discussed is PDCD1; the disease is neoplasm.